Table of Contents
ISRN AIDS
Volume 2013, Article ID 491601, 7 pages
http://dx.doi.org/10.1155/2013/491601
Clinical Study

Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia: A Hospital-Based Retrospective Cohort Study

1Department of Public Health, College of Health and Medical Sciences, Haramaya University, P.O. Box 235, Harar, Ethiopia
2Department of Epidemiology and Biostatistics, School of Public Health, Addis Ababa University, P.O. Box 25819/1000, Addis Ababa, Ethiopia

Received 16 December 2012; Accepted 16 January 2013

Academic Editors: V. C. Bond and V. Venketaraman

Copyright © 2013 Mitiku Teshome Hambisa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. AIDS Epidemic Update, UNAIDS, Geneva, Switzerland, 2009.
  2. WHO, UNAIDS and UNICEF, “GLOBAL HIV/AIDS response epidemic update and health sector progress towards universal access,” Progress Report, 2011. View at Google Scholar
  3. Guide for Implementation of the Antiretroviral Therapy Program in Ethiopia, Federal HIV/AIDS Prevention and Control Office Federal Ministry of Health Ethiopia, Addis Ababa, Ethiopia, 2007.
  4. Country Progress Report on HIV/AIDS Response, FHAPCO, Addis Ababa, Ethiopia, 2012.
  5. Report on Progress towards Implementation of the UN Declaration of Commitment on HIV/AIDS, Federal HIV/AIDS Prevention and Control Office Federal Ministry of Health Ethiopia, Addis Ababa, Ethiopia, 2010.
  6. B. O. Ojikutu, H. Zheng, R. P. Walensky et al., “Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa,” South African Medical Journal, vol. 98, no. 3, pp. 204–208, 2008. View at Google Scholar
  7. Z. Mulissa, D. Jerene, and B. Lindtjørn, “Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia,” PLoS ONE, vol. 5, no. 10, Article ID e13268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Worku and M. San Sebastián, “Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia,” Global Health Action, vol. 3, article 5398, 2010. View at Publisher · View at Google Scholar
  9. A. Johannessen, E. Naman, B. J. Ngowi et al., “Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania,” BMC Infectious Diseases, vol. 8, article 52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Sieleunou, M. Souleymanou, A. M. Schönenberger, J. Menten, and M. Boelaert, “Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon,” Tropical Medicine and International Health, vol. 14, no. 1, pp. 36–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. G. Pacheco, S. H. Tuboi, S. B. May et al., “Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil,” Journal of Acquired Immune Deficiency Syndromes, vol. 51, no. 5, pp. 624–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Nekemte Referral Hospital Annual ART Report 2005–2012, Nekemte Referral Hospital, Nekemte, Ethiopia, 2012.
  13. D. Jerene, A. Næss, and B. Lindtjørn, “Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients,” AIDS Research and Therapy, vol. 3, no. 1, article 10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bedru, Assessment of predictors of survival in patients living with HIV/AIDS after the advent of highly active antiretroviral therapy in Addis Ababa Ethiopia [MPH thesis], School of Public Health, Addis Ababa University, 2009.
  15. R. Zachariah, M. Fitzgerald, M. Massaquoi et al., “Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi,” AIDS, vol. 20, no. 18, pp. 2355–2360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Grabar, L. Weiss, and D. Costagliola, “HIV infection in older patients in the HAART era,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 1, pp. 4–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Abaasa, J. Todd, K. Ekoru et al., “Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of the AIDS Support Organization (TASO), Kampala, Uganda,” BMC Health Services Research, vol. 8, article 241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. WHO/UNAIDS/UNICEF, “Towards universal access: scaling-up priority HIV/AIDS intervention in the health sector,” Progress Report, pp. 122–132, 2009. View at Google Scholar
  19. F. Maggiolo, M. Airoldi, H. D. Kleinloog et al., “Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients,” HIV Clinical Trials, vol. 8, no. 5, pp. 282–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. E. H. Geng, D. V. Glidden, N. Emenyonu et al., “Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa,” Tropical Medicine and International Health, vol. 15, no. 1, pp. 63–69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. C. C. Chen, J. K. L. Yu, A. D. Harries et al., “Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi,” Tropical Medicine and International Health, vol. 13, no. 4, pp. 513–519, 2008. View at Publisher · View at Google Scholar · View at Scopus